Published in Proc Natl Acad Sci U S A on July 02, 2007
Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn (2008) 2.51
Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride. Proc Natl Acad Sci U S A (2009) 1.15
Chemoselective 15N tag for sensitive and high-resolution nuclear magnetic resonance profiling of the carboxyl-containing metabolome. Anal Chem (2009) 1.14
Advances in NMR-based biofluid analysis and metabolite profiling. Analyst (2010) 1.14
Multidimensional approaches to NMR-based metabolomics. Anal Chem (2013) 1.12
Systematic NMR analysis of stable isotope labeled metabolite mixtures in plant and animal systems: coarse grained views of metabolic pathways. PLoS One (2008) 1.11
Analysis of bacterial biofilms using NMR-based metabolomics. Future Med Chem (2012) 1.11
High-precision frequency measurements: indispensable tools at the core of the molecular-level analysis of complex systems. Anal Bioanal Chem (2007) 1.10
Quantitative analysis of blood plasma metabolites using isotope enhanced NMR methods. Anal Chem (2010) 1.05
Can NMR solve some significant challenges in metabolomics? J Magn Reson (2015) 0.98
Urinary amino acid analysis: a comparison of iTRAQ-LC-MS/MS, GC-MS, and amino acid analyzer. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.97
15N-cholamine--a smart isotope tag for combining NMR- and MS-based metabolite profiling. Anal Chem (2013) 0.92
Application of 31P NMR spectroscopy and chemical derivatization for metabolite profiling of lipophilic compounds in human serum. Magn Reson Chem (2009) 0.91
13C-formylation for improved nuclear magnetic resonance profiling of amino metabolites in biofluids. Anal Chem (2010) 0.91
Hyperpolarized NMR probes for biological assays. Sensors (Basel) (2014) 0.89
Ratio analysis nuclear magnetic resonance spectroscopy for selective metabolite identification in complex samples. Anal Chem (2011) 0.88
Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology (2009) 0.87
"Add to subtract": a simple method to remove complex background signals from the 1H nuclear magnetic resonance spectra of mixtures. Anal Chem (2011) 0.79
Dynamics of Positional Enrichment: Theoretical Development and Application to Carbon Labeling in Zymomonas mobilis. Biochem Eng J (2008) 0.77
Combining Hydrophilic Interaction Chromatography (HILIC) and Isotope Tagging for Off-Line LC-NMR Applications in Metabolite Analysis. Metabolites (2013) 0.76
Isotope enhanced approaches in metabolomics. Adv Exp Med Biol (2012) 0.75
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica (1999) 9.04
Metabolite profiling for plant functional genomics. Nat Biotechnol (2000) 8.74
The use of cyanate for the determination of NH2-terminal residues in proteins. J Biol Chem (1963) 4.85
Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat Med (2002) 3.91
High-resolution 1H-NMR spectroscopy of blood plasma for metabolic studies. Clin Chem (1994) 3.08
13C NMR studies of gluconeogenesis in rat liver cells: utilization of labeled glycerol by cells from euthyroid and hyperthyroid rats. Proc Natl Acad Sci U S A (1979) 2.19
Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry. Anal Chem (2006) 2.04
Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem (2007) 1.99
Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics. Int J Cancer (2005) 1.84
Statistical heterospectroscopy, an approach to the integrated analysis of NMR and UPLC-MS data sets: application in metabonomic toxicology studies. Anal Chem (2006) 1.61
Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Anal Bioanal Chem (2006) 1.30
13C NMR study of effects of fasting and diabetes on the metabolism of pyruvate in the tricarboxylic acid cycle and the utilization of pyruvate and ethanol in lipogenesis in perfused rat liver. Biochemistry (1987) 1.23
Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation. Rapid Commun Mass Spectrom (2006) 1.16
Effects of insulin on perfused liver from streptozotocin-diabetic and untreated rats: 13C NMR assay of pyruvate kinase flux. Biochemistry (1987) 1.14
A comparison of 13C nuclear magnetic resonance and 14C tracer studies of hepatic metabolism. J Biol Chem (1981) 1.12
Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem (1995) 1.08
Use of semiselective TOCSY and the pearson correlation for the metabonomic analysis of biofluid mixtures: application to urine. Anal Chem (2005) 1.08
Acetylation of amino and tyrosine hydroxyl groups. Preparation of inhibitors of oxytocin with no intrinsic activity on the isolated uterus. J Biol Chem (1967) 1.03
N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin Chem (2003) 1.00
Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin Chem (1999) 0.99
Malabsorption syndrome with and without small intestinal bacterial overgrowth: a study on upper-gut aspirate using 1H NMR spectroscopy. Magn Reson Med (2006) 0.96
1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed (2006) 0.94
Cryogenic probe 13C NMR spectroscopy of urine for metabonomic studies. Anal Chem (2002) 0.93
beta-Ureidopropionase deficiency: a novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magn Reson Med (2001) 0.85
Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias. Clin Chem (1985) 0.83
Metabonomics and biomarker discovery: LC-MS metabolic profiling and constant neutral loss scanning combined with multivariate data analysis for mercapturic acid analysis. Anal Chem (2006) 0.83
Rapid 3D NMR using the filter diagonalization method: application to oligosaccharides derivatized with 13C-labeled acetyl groups. J Magn Reson (2004) 0.81
13C NMR spectroscopy: a convenient tool for detection of argininosuccinic aciduria. J Pharm Biomed Anal (2001) 0.78
Nuclear magnetic resonance spectroscopy of peracetylated oligosaccharides having 13C-labeled carbonyl groups in lieu of permethylation analysis for establishing linkage substitutions of sugars. Carbohydr Res (1999) 0.78
Benzoyl derivatization as a method to improve retention of hydrophilic peptides in tryptic peptide mapping. Anal Chem (2004) 0.78
Reevaluation of the reaction of formaldehyde at low concentration with amino acids. J Biochem (1980) 0.78
Metabolomics-based methods for early disease diagnostics. Expert Rev Mol Diagn (2008) 2.51
Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem (2007) 1.99
Early detection of recurrent breast cancer using metabolite profiling. Cancer Res (2010) 1.61
NMR-based metabolomics study of canine bladder cancer. Biochim Biophys Acta (2012) 1.59
Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes. PLoS One (2010) 1.53
Solvent signal as an NMR concentration reference. Anal Chem (2008) 1.35
Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism. Anal Bioanal Chem (2006) 1.30
Altered proteome turnover and remodeling by short-term caloric restriction or rapamycin rejuvenate the aging heart. Aging Cell (2014) 1.30
Hyperammonemia in the ICU. Chest (2007) 1.29
Use of selective TOCSY NMR experiments for quantifying minor components in complex mixtures: application to the metabonomics of amino acids in honey. Anal Chem (2005) 1.26
R: A quantitative measure of NMR signal receiving efficiency. J Magn Reson (2009) 1.21
Correlative and quantitative 1H NMR-based metabolomics reveals specific metabolic pathway disturbances in diabetic rats. Anal Biochem (2008) 1.20
Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods. PLoS One (2012) 1.20
Metabolic signatures of bacterial vaginosis. MBio (2015) 1.18
Combining desorption electrospray ionization mass spectrometry and nuclear magnetic resonance for differential metabolomics without sample preparation. Rapid Commun Mass Spectrom (2006) 1.16
Chemoselective 15N tag for sensitive and high-resolution nuclear magnetic resonance profiling of the carboxyl-containing metabolome. Anal Chem (2009) 1.14
Advances in NMR-based biofluid analysis and metabolite profiling. Analyst (2010) 1.14
Principal component directed partial least squares analysis for combining nuclear magnetic resonance and mass spectrometry data in metabolomics: application to the detection of breast cancer. Anal Chim Acta (2010) 1.13
Design and construction of a versatile dual volume heteronuclear double resonance microcoil NMR probe. J Magn Reson (2008) 1.11
Colorectal cancer detection using targeted serum metabolic profiling. J Proteome Res (2014) 1.09
Use of semiselective TOCSY and the pearson correlation for the metabonomic analysis of biofluid mixtures: application to urine. Anal Chem (2005) 1.08
Pre-SAT180, a simple and effective method for residual water suppression. J Magn Reson (2007) 1.07
Identification and quantification of metabolites in (1)H NMR spectra by Bayesian model selection. Bioinformatics (2011) 1.07
1H NMR metabolomics study of age profiling in children. NMR Biomed (2009) 1.06
Quantitative analysis of blood plasma metabolites using isotope enhanced NMR methods. Anal Chem (2010) 1.05
Signal enhancement in HPLC/microcoil NMR using automated column trapping. Anal Chem (2006) 1.02
Epibatidine binds to four sites on the Torpedo nicotinic acetylcholine receptor. Biochem Biophys Res Commun (2007) 1.00
Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol Oncol (2012) 0.99
Metabolomics study of esophageal adenocarcinoma. J Thorac Cardiovasc Surg (2010) 0.99
Interdependence of signal processing and analysis of urine 1H NMR spectra for metabolic profiling. Anal Chem (2009) 0.97
Monitoring diet effects via biofluids and their implications for metabolomics studies. Anal Chem (2007) 0.97
Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment. J Neurosci (2012) 0.97
Radical scavenging and cytochrome P450 3A4 inhibitory activity of bergaptol and geranylcoumarin from grapefruit. Bioorg Med Chem (2007) 0.95
Targeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MS. Electrophoresis (2013) 0.94
Quantitating metabolites in protein precipitated serum using NMR spectroscopy. Anal Chem (2014) 0.94
1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed (2006) 0.94
Inhibition of colon cancer cell growth and antioxidant activity of bioactive compounds from Poncirus trifoliata (L.) Raf. Bioorg Med Chem (2007) 0.93
15N-cholamine--a smart isotope tag for combining NMR- and MS-based metabolite profiling. Anal Chem (2013) 0.92
13C-formylation for improved nuclear magnetic resonance profiling of amino metabolites in biofluids. Anal Chem (2010) 0.91
High-throughput nuclear magnetic resonance analysis using a multiple coil flow probe. Anal Chem (2003) 0.91
Application of 31P NMR spectroscopy and chemical derivatization for metabolite profiling of lipophilic compounds in human serum. Magn Reson Chem (2009) 0.91
Inhibition of adherence of multi-drug resistant E. coli by proanthocyanidin. Urol Res (2011) 0.90
Targeted serum metabolite profiling of nucleosides in esophageal adenocarcinoma. Rapid Commun Mass Spectrom (2010) 0.90
Receiver gain function: the actual NMR receiver gain. Magn Reson Chem (2010) 0.90
Statistical analysis and modeling of mass spectrometry-based metabolomics data. Methods Mol Biol (2014) 0.89
Expanding the limits of human blood metabolite quantitation using NMR spectroscopy. Anal Chem (2014) 0.89
Ratio analysis nuclear magnetic resonance spectroscopy for selective metabolite identification in complex samples. Anal Chem (2011) 0.88
Metabolic profiling: are we en route to better diagnostic tests for cancer? Future Oncol (2012) 0.87
Nuclear magnetic resonance spectroscopy-based metabolomics of the fatty pancreas: implicating fat in pancreatic pathology. Pancreatology (2009) 0.87
Ibuprofen metabolite profiling using a combination of SPE/column-trapping and HPLC-micro-coil NMR. J Pharm Biomed Anal (2007) 0.87
1H NMR spectroscopic method for diagnosis of malabsorption syndrome: a pilot study. NMR Biomed (2004) 0.85
RAMSY: ratio analysis of mass spectrometry to improve compound identification. Anal Chem (2013) 0.85
Protonation of trimipramine salts of maleate, mesylate and hydrochloride observed by 1H, 13C and 15N NMR spectroscopy. Magn Reson Chem (2005) 0.85
Susceptibility-matched plugs for microcoil NMR probes. J Magn Reson (2010) 0.84
(1)H NMR spectroscopy in the diagnosis of Pseudomonas aeruginosa-induced urinary tract infection. NMR Biomed (2005) 0.84
Pyruvate carboxylase deficiency--insights from liver transplantation. Mol Genet Metab (2002) 0.83
1,25-dihydroxyvitamin D regulation of glucose metabolism in Harvey-ras transformed MCF10A human breast epithelial cells. J Steroid Biochem Mol Biol (2013) 0.83
Identification of 4-deoxythreonic acid present in human urine using HPLC and NMR techniques. J Pharm Biomed Anal (2009) 0.83
Simultaneous Analysis of Major Coenzymes of Cellular Redox Reactions and Energy Using ex Vivo (1)H NMR Spectroscopy. Anal Chem (2016) 0.82
Altered glucose metabolism in Harvey-ras transformed MCF10A cells. Mol Carcinog (2013) 0.82
1H and 13C NMR characterization and stereochemical assignments of bile acids in aqueous media. Lipids (2005) 0.82
Novel triterpenoid from Citrus aurantium L. possesses chemopreventive properties against human colon cancer cells. Bioorg Med Chem (2008) 0.81
An approaching new wave of multicomponent biomarker diagnostics? J Urol (2008) 0.81
Headspace SPME-GC-MS metabolomics analysis of urinary volatile organic compounds (VOCs). Methods Mol Biol (2014) 0.81
New Solenoidal Microcoil NMR Probe Using Zero-Susceptibility Wire. Concepts Magn Reson Part B Magn Reson Eng (2010) 0.81
Metabolomics method to comprehensively analyze amino acids in different domains. Analyst (2015) 0.81
Improved residual water suppression: WET180. J Biomol NMR (2008) 0.80
A new dimension of 1H-NMR spectroscopy in assessment of liver graft dysfunction. NMR Biomed (2003) 0.80
"Add to subtract": a simple method to remove complex background signals from the 1H nuclear magnetic resonance spectra of mixtures. Anal Chem (2011) 0.79
Bile acids conjugation in human bile is not random: new insights from (1)H-NMR spectroscopy at 800 MHz. Lipids (2009) 0.79
Recent Advances in NMR-Based Metabolomics. Anal Chem (2016) 0.78
In vitro (1)H NMR studies of RD human cell infection with echovirus 11. NMR Biomed (2007) 0.78
Analysis of porosity in porous silicon using hyperpolarized 129Xe two-dimensional exchange experiments. Solid State Nucl Magn Reson (2005) 0.78
NMR difference spectroscopy with a dual saddle-coil difference probe. Anal Bioanal Chem (2004) 0.78
Massive glutamine cyclization to pyroglutamic acid in human serum discovered using NMR spectroscopy. Anal Chem (2015) 0.78
Simple pulse-acquire NMR methods for the quantitative analysis of calcium, magnesium and sodium in human serum. Spectrochim Acta A Mol Biomol Spectrosc (2006) 0.78
Neonatal Graves' disease associated with severe metabolic abnormalities. Pediatrics (2011) 0.78
Use of optimized 1D TOCSY NMR for improved quantitation and metabolomic analysis of biofluids. J Biomol NMR (2011) 0.78
Frozen-solution conformational analysis by REDOR spectroscopy. J Am Chem Soc (2003) 0.77
Saturation transfer double-difference NMR spectroscopy using a dual solenoid microcoil difference probe. Magn Reson Chem (2008) 0.77
Structural analysis of synthetic peptide fragments from EmrE, a multidrug resistance protein, in a membrane-mimetic environment. Biochemistry (2002) 0.77
Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor. Biochem Pharmacol (2006) 0.77
Targeted plasma metabolome response to variations in dietary glycemic load in a randomized, controlled, crossover feeding trial in healthy adults. Food Funct (2015) 0.77
NMR quantitation: influence of RF inhomogeneity. Magn Reson Chem (2011) 0.77
1H NMR study of the effects of sample contamination in the metabolomic analysis of mouse urine. J Pharm Biomed Anal (2007) 0.77
Visualization of bile homeostasis using (1)H-NMR spectroscopy as a route for assessing liver cancer. Lipids (2008) 0.76
A quick diagnostic test for NMR receiver gain compression. Magn Reson Chem (2010) 0.76
Bioactive compounds from sour orange inhibit colon cancer cell proliferation and induce cell cycle arrest. J Agric Food Chem (2010) 0.75
Kinetics of agonist-induced intrinsic fluorescence changes in the Torpedo acetylcholine receptor. J Biochem (2010) 0.75
Quantitative analysis of urea in human urine and serum by 1H nuclear magnetic resonance. Analyst (2011) 0.75
Isotope enhanced approaches in metabolomics. Adv Exp Med Biol (2012) 0.75
Rapid separation and quantitation of curcuminoids combining pseudo two-dimensional liquid flash chromatography and NMR spectroscopy. J Chromatogr B Analyt Technol Biomed Life Sci (2013) 0.75